Cognitive Impairment in Relapsing Remitting and Secondary Progressive Multiple Sclerosis Patients: Efficacy of a Computerized Cognitive Screening Battery

Table 1

Demographic and clinical characteristics of patients and controls.

	Controls	RRMS	SPMS	Significant differences
𝑁	31	50	30
Age (years)	40.742 (2.695)	41.760 (11.289)	48.800 (6.228)	RRMS<SPMS
Education (years)	12.935 (1.093)	12.260 (3.556)	12.667 (3.262)	n.s.
Gender M/F, %	38.7/61.3	22/78	26.7/73.3	n.s.
EDSS		3.050 (0.810)	6.183 (0.623)	RRMS<SPMS
Duration (years)		8.840 (4.053)	15.800 (5.135)	RRMS<SPMS
Hand, R/L %	90.2/9.8	94/6	93.3/6.7	n.s.

Values are mean (SD); 𝜒² test for gender and hand, Kruskal-Wallis test for age, education, Mann-Whitney 𝑈 test for EDSS, duration.
RRMS: relapsing remitting multiple sclerosis, SPMS: secondary progressive multiple sclerosis.
n.s: nonsignificant.
Significant differences: RRMS < SPMS with 𝑃<0.001.